Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Assessment of Cell Proliferation Inhibition Rate Using CCK-8 Assay

The CCK-8 assay is a rapid and highly sensitive colorimetric method widely used for determining cell viability and assessing the cell proliferation inhibition rate in various biological studies. By utilizing water-soluble tetrazolium salts, this technique offers a non-radioactive and safe approach to quantifying the cytotoxic effects of drugs on cell populations. This article provides a comprehensive technical overview of the CCK-8 protocol, calculation methods, and its critical applications in drug discovery and toxicology research.

CCK8

Technical Overview

The Cell Counting Kit-8 (CCK-8) assay serves as a standard laboratory technique for evaluating cell proliferation and cytotoxicity. It utilizes a water-soluble tetrazolium salt, WST-8, which is reduced by dehydrogenase activities in living cells to produce an orange-colored formazan dye. The amount of formazan dye generated is directly proportional to the number of living cells, allowing researchers to quantitatively assess the cell proliferation inhibition rate. This method is favored for its high sensitivity, safety, and convenience compared to traditional radioactive or MTT assays.

Testing Samples

Tumor Cell Lines

Various human and animal tumor cell lines are commonly used to evaluate the efficacy of anti-cancer drugs. These cells are cultured in vitro and exposed to different concentrations of therapeutic agents to measure growth suppression.

Primary Cells

Primary cells isolated directly from tissues, such as hepatocytes or fibroblasts, are utilized to assess drug toxicity and safety profiles. These cells often provide a more physiologically relevant model than immortalized cell lines.

Drug-Treated Cell Populations

Cultured cells treated with specific inhibitors, natural extracts, or pharmaceutical compounds form the core sample group for determining dose-response relationships and calculating inhibition rates.

Testing Items

  • Cell Viability Analysis
  • Cell Proliferation Inhibition Rate Calculation
  • Half Maximal Inhibitory Concentration (IC50) Determination
  • Cytotoxicity Screening of Compounds
  • Cell Growth Curve Generation

Testing Methods

The assessment involves a standardized protocol to ensure accurate measurement of the cell proliferation inhibition rate. The process requires careful handling to maintain cell integrity and consistent environmental conditions.

Experimental Procedure

  • Cell Seeding: Cells are seeded into a 96-well plate at a density optimized to avoid over-confluence, typically ranging from 1,000 to 10,000 cells per well, and incubated overnight.
  • Drug Treatment: Serial dilutions of the test compound are added to the wells, while control wells receive only the culture medium or a vehicle control. The plate is incubated for a designated period, usually 24 to 72 hours.
  • Reagent Addition: A specific volume of CCK-8 solution, typically 10% of the culture volume, is added to each well. The plate is incubated for an additional 1 to 4 hours to allow formazan production.
  • Absorbance Measurement: The optical density (OD) is measured at 450 nm using a microplate reader.

Data Analysis

The cell proliferation inhibition rate is calculated using the absorbance values. The formula typically applied is: Inhibition Rate (%) = [1 - (OD_treated - OD_blank) / (OD_control - OD_blank)] x 100%. The OD_blank refers to wells containing medium and CCK-8 reagent but no cells. This data is used to generate dose-response curves and calculate IC50 values using statistical software.

Applications

The CCK-8 assay is extensively applied in biomedical research and the pharmaceutical industry. It is a critical tool for high-throughput drug screening, enabling researchers to quickly identify promising therapeutic candidates. In toxicology studies, it helps evaluate the potential risks of chemical substances to human health. Additionally, this method is employed in cancer research to investigate the mechanisms of drug resistance and the synergistic effects of combination therapies.

FAQ

What are the advantages of CCK-8 over MTT assays?

The CCK-8 solution is more sensitive and water-soluble, eliminating the need for organic solvents like DMSO to dissolve the formazan crystals, which is required in MTT assays. Furthermore, CCK-8 is less toxic to cells, allowing for continuous incubation and potential subsequent cell culture.

How can bubble formation be prevented during the assay?

Bubbles can interfere with absorbance readings. To prevent them, pipette tips should be changed regularly, and the CCK-8 reagent should be added gently to the side of the well or into the medium without introducing air.

Why might the OD value be too low?

Low OD values may result from an insufficient number of cells, short incubation times with the CCK-8 reagent, or low metabolic activity of the cells. Optimizing the seeding density and incubation time is recommended to ensure the OD values fall within the linear range of the standard curve.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing